Study: NCT04918147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Premedication administered intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Premedication administered intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: Premedication administered intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: methylprednisolone
Description: Premedication administered intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diphenhydramine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diphenhydramine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diphenhydramine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: diphenhydramine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acetaminophen
Description: Premedication administered orally, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acetaminophen
Description: Premedication administered orally, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acetaminophen
Description: Premedication administered orally, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: acetaminophen
Description: Premedication administered orally, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: famotidine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: famotidine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: famotidine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: famotidine
Description: Premedication administered orally or intravenously, 45 to 90 minutes prior to each elotuzumab/placebo infusion, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Prescribed dosing with prednisone begins on the day of the first elotuzumab/placebo infusion, administered orally. The ten-week dosing taper proceeds, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Prescribed dosing with prednisone begins on the day of the first elotuzumab/placebo infusion, administered orally. The ten-week dosing taper proceeds, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Prescribed dosing with prednisone begins on the day of the first elotuzumab/placebo infusion, administered orally. The ten-week dosing taper proceeds, per protocol. Dosage in milligrams (mg).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: prednisone
Description: Prescribed dosing with prednisone begins on the day of the first elotuzumab/placebo infusion, administered orally. The ten-week dosing taper proceeds, per protocol. Dosage in milligrams (mg).